期刊文献+

复方卡力孜然酊联合他克莫司软膏治疗儿童白癜风疗效观察 被引量:3

Clinical Curative Effect of Compound Kaliziranding Combined with Tacrolimus Ointment Treatment of Children Vitiligo
下载PDF
导出
摘要 目的:观察复方卡力孜然酊联合他克莫司外用治疗儿童白癜风临床疗效。方法:采用单盲随机对照试验的研究方法,将63例白癜风患儿随机分为治疗组32例和对照组31例,治疗组外用复方卡力孜然酊联合他克莫司软膏,连续3个月,对照组外用复方卡力孜然酊,观察两组的临床疗效。结果:治疗组和对照组的有效率分别为62.50%和48.39%,两组差异有统计学意义(P<0.01)。结论:复方卡力孜然酊联合他克莫司治疗儿童白癜风疗效确切,二者联合具有协同作用,值得临床推广应用。 Objective: To observe the clinical curative effect of compound Kaliziranding combined with tacrolimus ointment treatment of children vitiligo. Methods: Using the method of random, single blind, controlled, 63 cases of children were randomly divided into treatment group (32 cases) and control group (31 cases). The treatment group received topical compound Kaliziranding combined with tacrolimus ointment, successive 3 months. The control group received topical compound Kaliziranding respectively. The clinical curative effect was observed. Results: The total effective rate of the treatment group and the control group was 62. 50% and 48. 39% respectively, the difference was statistically significant (P〈0.05). Conclusion: Compound Kaliziranding combined with tacrolimus ointment play a complementary role in treating children with vitiligo. It is worthy of clinical application.
作者 宋远
出处 《儿科药学杂志》 CAS 2015年第1期15-17,共3页 Journal of Pediatric Pharmacy
关键词 儿童 白癜风 复方卡力孜然酊 他克莫司软膏 Children Vitiligo Compound Kaliziranding Tacrolimus ointment
  • 相关文献

参考文献2

二级参考文献20

  • 1Kanwar AJ,Dogra S,Parsad D.Topical tacrolimus for treatment of childhood vitiligo in Asians.Clin Exp Dermatol,2004,29:589-592.
  • 2Lepe V,Moncada B,Castanedo-Cazares JP,et al.A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.Arch Dermatol,2003,139:581-585.
  • 3Silverberg NB,Lin P,Travis L,et al.Tacrolimus ointment promotes repigmentation of vitiligo in children:a review of 57 cases.J Am Acad Dermatol,2004,51:760-766.
  • 4Reitamo S,Rissanen J,Remitz A,et al.Tacrolimus ointment does not affect collagen synthesis:results of a single-center randomized trial.J Invest Dermatol,1998,111:396-398.
  • 5Kovacs SO.Vitiligo.J Am Acad Dermatol,1998,38(5 Pt 1):647-666.
  • 6Caixia T,Hongwen F,Xiran L.Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.J Dermatol Sci,1999,21:59-62.
  • 7Wang X,Erf GF.Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo.J Autoimmun,2004,22:21-30.
  • 8Wang X,Erf GF.Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens.J Autoimmun,2003,21:149-160.
  • 9Austin LM,Boissy RE.Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens.An avian model for human vitiligo.Am J Pathol,1995,146:1529-1541.
  • 10Ruzicka T,Assmann T,Homey B.Tacrolimus:the drug for the turn of the millennium? Arch Dermatol,1999,135:574-580.

共引文献384

同被引文献38

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部